Biologic, demographic, and social factors affecting triple negative breast cancer outcomes.

Abstract:

BACKGROUND:Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype that disproportionately affects women who are African American, younger, or carriers of the BRCA1 gene. No targeted treatments exist for the disease, which has distinct features and presents unique challenges to patients who have been diagnosed with it. OBJECTIVES:TNBC is reviewed in this article according to incidence, tumor grade, stage of diagnosis, biologic and social risk factors, mortality, and treatment. METHODS:Published articles pertaining to TNBC and located through online database searches were reviewed. Articles were selected either because they offered the most current information about TNBC or contributed to the understanding of TNBC. FINDINGS:Biologic, demographic, and social factors present unique challenges in the treatment of women with TNBC. Knowing about the characteristics of TNBC and the populations who are most at risk for the disease might help healthcare providers better respond to their patients. It may also facilitate responsiveness to patients' needs and enhance their quality of life.

journal_name

Clin J Oncol Nurs

authors

Turkman YE,Sakibia Opong A,Harris LN,Knobf MT

doi

10.1188/15.CJON.62-67

subject

Has Abstract

pub_date

2015-02-01 00:00:00

pages

62-7

issue

1

eissn

1092-1095

issn

1538-067X

journal_volume

19

pub_type

杂志文章,评审
  • Putting Evidence into Practice: nursing assessment and interventions to reduce family caregiver strain and burden.

    abstract::Family caregiving often is associated with multiple rewards, yet the diversity and intensity of caregiving roles also can result in caregiver strain and burden. Using interventions to reduce the strain and burden on caregivers of patients with cancer is an important role nurses play. This article is a critical review ...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/08.CJON.507-516

    authors: Honea NJ,Brintnall R,Given B,Sherwood P,Colao DB,Somers SC,Northouse LL

    更新日期:2008-06-01 00:00:00

  • Understanding bodywork for the patient with cancer.

    abstract::The goal of this article is to increase oncology nurses' understanding of common bodywork modalities and the current research about them in the oncology setting. Bodywork is a broad term that incorporates massage and energy modalities. Eleven modalities are described. In addition, issues related to safety, licensure, ...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/05.CJON.733-739

    authors: Coe AB,Anthony ML

    更新日期:2005-12-01 00:00:00

  • Prediction of adverse events in patients receiving rapid rituximab infusion: validation of a predictive model.

    abstract::Rapid rituximab infusion was approved as treatment for non-Hodgkin lymphoma by the U.S. Food and Drug Administration in 2012, but it has been administered clinically since approval of the drug rituximab in 1997. Because of the delay between the approval of the drug and the approval of the procedure, researchers sought...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/14.CJON.89-92

    authors: Lang DS,Fong CC

    更新日期:2014-02-01 00:00:00

  • Factors affecting genetic testing and decisions about prophylactic surgery.

    abstract::Both of the articles reviewed here as well as the references, suggest that very little is actually known about the impact of many aspects of genetic testing. How decision are made about genetic testing in people who do not have cancer, how the results of testing are used used to guide care, and ultimately how people a...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:

    authors: Mahon SM

    更新日期:2001-05-01 00:00:00

  • Management of patients who have undergone hepatic artery chemoembolization.

    abstract::Hepatocellular carcinoma (HCC) is the fifth most common cause of all malignancies and causes approximately one million deaths each year. Surgical liver resection is the only cure for HCC; however, few patients are eligible to undergo this procedure. Hepatic artery chemoembolization (HACE) is a technique that delivers ...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/05.CJON.69-75

    authors: Cahill BA

    更新日期:2005-02-01 00:00:00

  • Practical management of imatinib in gastrointestinal stromal tumors.

    abstract::Gastrointestinal stromal tumors (GISTs) have an incidence of 7-15 occurrences per million people. Tyrosine kinase inhibitors (TKIs) have significantly improved clinical outcomes as part of multidisciplinary disease management. The authors will review developments in the management of GISTs, including diagnosis, risk s...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/11.CJON.533-545

    authors: Barnes T,Reinke D

    更新日期:2011-10-01 00:00:00

  • Mediterranean Diet: Outcomes from an Education Session Among Patients With Cancer and Nursing Staff.

    abstract:BACKGROUND:Strong evidence supports the benefits of the Mediterranean diet, but little is reported among patients and nurses regarding knowledge about the diet and its health benefits. OBJECTIVES:A pre-/post-test practice initiative was implemented to identify level of knowledge about the Mediterranean diet in patient...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/20.CJON.177-185

    authors: Otten KR,Staffileno BA,Mozer M,Maidlow C

    更新日期:2020-04-01 00:00:00

  • Trastuzumab cardio-oncology: lessons learned.

    abstract::Treatment with the humanized monoclonal antibody trastuzumab can significantly improve outcomes for patients with early or metastatic HER2-positive breast cancer. In a small proportion of patients, trastuzumab is associated with an increased risk of cardiac dysfunction. Although the mechanisms have yet to be fully est...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/10.CJON.630-640

    authors: Frankel C

    更新日期:2010-10-01 00:00:00

  • The rationale for fractionation in radiotherapy.

    abstract::The use of radiotherapy as a cancer treatment is common, so an appreciation of the biologic effects of radiation at a cellular level is essential to help nurses prepare their patients for the challenging journey ahead using appropriate lay language. The four Rs of radiotherapy (repair, redistribution, reoxygenation, a...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/13.CJON.412-417

    authors: Mitchell G

    更新日期:2013-08-01 00:00:00

  • Suboptimal responses to imatinib in chronic myelogenous leukemia: what are they and how do they affect treatment?

    abstract::First-line treatment for chronic myelogenous leukemia (CML) is imatinib, but some patients do not respond or develop resistance to the drug, leading to suboptimal responses. Dasatinib and nilotinib are approved second-line compounds for patients experiencing imatinib failure. In a prospective comparison of dasatinib w...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/09.CJON.537-542

    authors: Allen-Bard S

    更新日期:2009-10-01 00:00:00

  • Colorectal Cancer Screening: An Educational Intervention for Nurse Practitioners to Increase Screening Awareness and Participation
.

    abstract::Colorectal cancer screening aims to detect colorectal cancer at an early stage, when treatment is more likely to be curative. Lack of participation in such screening is a major issue in primary care practices, where nurse practitioners (NPs) often provide care. This study aimed to determine whether an educational inte...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/17.CJON.543-546

    authors: Slyne TC,Gautam R,King V

    更新日期:2017-10-01 00:00:00

  • 5-Fluorouracil Infiltrations and Ambulatory Pumps: Education, Prevention, and Management Considerations.

    abstract::Although uncommon, 5-fluorouracil (5-FU) infiltrations do occur. Two case studies involving 5-FU infiltration from totally implanted venous access devices identified at the conclusion of a 46-hour continuous infusion via an ambulatory infusion pump are presented. These cases highlight the importance of patient and car...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/19.CJON.537-539

    authors: Bostelman C

    更新日期:2019-10-01 00:00:00

  • Taste alterations among patients with cancer.

    abstract::Patients with cancer frequently develop taste alterations, which are manifested by food aversions and decreased caloric intake. Many etiologies are recognized, including the effect of tumors, cancer cell mitosis, vitamin deficiencies, and cytokine involvement. Preventing or improving taste alterations in patients with...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/02.CJON.73-77

    authors: Sherry VW

    更新日期:2002-03-01 00:00:00

  • Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.

    abstract::Hyperviscosity syndrome can develop in patients with plasma cell dyscrasias, particularly Waldenstrom macroglobulinemia (WM). Occurring in 10%-30% of patients with hyperviscosity syndrome, WM is an uncommon B-cell proliferative disorder characterized by bone marrow infiltration and production of monoclonal immunoglobu...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/07.CJON.87-95

    authors: Mullen EC,Wang M

    更新日期:2007-02-01 00:00:00

  • Preventing and managing infections in neutropenic stem cell transplantation recipients: evidence-based review.

    abstract::The number of hematopoietic stem cell transplantations (HSCTs) performed annually is increasing. Although general survival rates have risen since 1990, mortality and morbidity from preventable complications can be improved. As a result, this article will review developments in preventing and managing infections in neu...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/11.CJON.133-139

    authors: Saria M

    更新日期:2011-04-01 00:00:00

  • Risk Prediction Tools in Oncology.

    abstract::Cancer prediction tools are widely available to clinicians, and the data retrieved from these tools can assist with patient counseling sessions on risk, prognosis, treatment, and recurrence. Current tools are able to synthesize data in a concise, unbiased, and evidence-based method, allowing patients to make better-in...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/15.CJON.665-666

    authors: Doyle-Lindrud S

    更新日期:2015-12-01 00:00:00

  • Providing palliative care in the ambulatory care setting.

    abstract::Palliative care that provides specialized attention to pain and symptom management is important for patients with cancer. Palliative care aims to reduce pain and other symptoms through an interdisciplinary approach involving physicians, nurses, social workers, and other members of the healthcare team. Families are inc...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/10.CJON.171-175

    authors: Griffith J,Lyman JA,Blackhall LJ

    更新日期:2010-04-01 00:00:00

  • Evaluating the frequency of vital sign monitoring during blood transfusion: an evidence-based practice initiative.

    abstract::Patients with cancer are often dependent on blood transfusions during treatment. Frequent vital sign monitoring during transfusions may interrupt sleep and the patient's ability to ambulate or participate in unit activities. Relying heavily on vital sign findings may also overshadow unmeasurable symptoms of transfusio...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/15.CJON.516-520

    authors: DeYoung Sullivan K,Vu T,Richardson G,Castillo E,Martinez F

    更新日期:2015-10-01 00:00:00

  • Helping nurses cope with grief and compassion fatigue: an educational intervention.

    abstract::Oncology nurses may experience intense physical and emotional exhaustion, identified in the literature as symptoms of cumulative grief and compassion fatigue, with significant consequences for both nurses and organizations. The first step in preventing these consequences is recognition. Organizations should provide nu...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/14.CJON.454-458

    authors: Houck D

    更新日期:2014-08-01 00:00:00

  • Screening for disease: making evidence-based choices.

    abstract::Screening for illness should be an evidence-based activity. Screening tests are useful only if they reduce mortality or morbidity. Therefore, healthcare professionals must know how to evaluate research about screening tests to be sure that, in fact, the tests actually accomplish their goals. Tests that generate many f...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/06.CJON.73-76

    authors: Fields MM,Chevlen E

    更新日期:2006-02-01 00:00:00

  • Ribavirin: the need for exposure precautions.

    abstract::Ribavirin is used in the treatment of respiratory syncytial virus (RSV) in high-risk patients, including patients who have undergone hematopoietic stem cell transplantation, to reduce mortality from RSV pneumonia. It is classified as a hazardous drug with potential for carcinogenicity and teratogenicity. Very few rece...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/14.CJON.E93-E96

    authors: Mooney K,Melvin M,Douglas T

    更新日期:2014-10-01 00:00:00

  • Lymphedema following breast cancer: regions affected, severity of symptoms, and benefits of treatment from the patients' perspective.

    abstract::Limited high-quality research has focused on the efficacy of lymphedema treatments and symptomatic relief. With that in mind, the authors conducted a cross-sectional survey to describe the presentation of breast cancer-related lymphedema, treatment modalities used, and perceived effectiveness. An electronic validated ...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/13.CJON.325-331

    authors: Sierla R,Lee TS,Black D,Kilbreath SL

    更新日期:2013-06-01 00:00:00

  • Managing late effects of breast cancer treatment.

    abstract::This article illustrates the authors' participation in the ONS Foundation-supported Breast Cancer Survivorship (BCS) Quality Measures Set pilot study at Southern Ohio Medical Center (SOMC) Cancer Center. The data collection, outcomes, and action plans based on results are described. Included are the SOMC distress tool...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/14.CJON.S2.32-35

    authors: Arnett J,Henry B,Fankell A

    更新日期:2014-01-01 00:00:00

  • Cardio-Oncology: A Continually Evolving Subspecialty in Oncology Nursing.

    abstract::Cardio-oncology is a unique subspecialty within oncology nursing that focuses on the assessment, identification, and management of cardiotoxicity induced or exacerbated by cancer treatment. Nurses are pivotal to the delivery of evidence-based assessment of and care for individuals who have preexisting cardiac conditio...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/21.CJON.93-96

    authors:

    更新日期:2021-02-01 00:00:00

  • Integrating a Question Prompt List on an Inpatient Oncology Unit to Increase Prognostic Awareness.

    abstract:BACKGROUND:Many patients with incurable cancer do not accurately understand their prognosis, which can lead to aggressive and, often, futile treatment. Improved prognostic awareness can help patients to appropriately de-escalate aggressive treatment sooner in an illness trajectory. OBJECTIVES:The purpose of this artic...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/16.CJON.385-390

    authors: McLawhorn VC,Vess J,Dumas BP

    更新日期:2016-08-01 00:00:00

  • Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.

    abstract::Temsirolimus is a targeted therapy that inhibits mammalian target of rapamycin (mTOR), a central regulator of tumor cell responses to growth stimuli. Temsirolimus has a broad anticancer activity profile that impacts tumor cell growth, proliferation, and survival through its specific inhibition of mTOR. In a randomized...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章,评审

    doi:10.1188/08.CJON.639-646

    authors: Malizzia LJ,Hsu A

    更新日期:2008-08-01 00:00:00

  • Neurologic Complications: Effects of Ipilimumab and Nivolumab Therapy in Patients With Metastatic Melanoma.

    abstract::Checkpoint inhibitors are a form of immunotherapy that have revolutionized treatment for malignant melanoma, resulting in longer survival and better disease control. Multiple autoimmune disorders can occur with the use of checkpoint inhibitors, including severe, potentially fatal neurologic complications. Although neu...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/19.CJON.355-358

    authors: Latchman J,Guastella A,Tofthagen C

    更新日期:2019-08-01 00:00:00

  • Tracking and journaling the cancer journey.

    abstract::Clinicians sometimes suggest to patients that they keep track of illness-related issues. Self-monitoring is a helpful term to describe these at-home activities that yield essential information for self-management. The purpose of this article is to create greater awareness of the opportunities (and potential shortcomin...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/14.CJON.388-391

    authors: Hermansen-Kobulnicky CJ,Purtzer MA

    更新日期:2014-08-01 00:00:00

  • Telomere-based cancer treatment: emerging targeted therapies.

    abstract::Chemotherapy and radiation therapy are standard care in cancer treatment; however, both have numerous adverse side effects because they affect healthy as well as cancerous cells. The side effects, including decreased white blood cell count, nausea, hair loss, and fatigue, can be severe enough that patients may decide ...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/10.CJON.720-726

    authors: Chen M,McLeskey SW

    更新日期:2010-12-01 00:00:00

  • Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institution.

    abstract:BACKGROUND:Sipuleucel-T, an autologous cellular immunotherapy, is approved for the treatment of certain patients with metastatic castration-resistant prostate cancer (mCRPC). Sipuleucel-T is the first personalized treatment for prostate cancer to be manufactured using the immune system of each individual patient. Patie...

    journal_title:Clinical journal of oncology nursing

    pub_type: 杂志文章

    doi:10.1188/15.CJON.297-303

    authors: Davis K,Wood S,Dill E,Fesko Y,Bitting RL,Harrison MR,Armstrong AJ,Moul JW,George DJ

    更新日期:2015-06-01 00:00:00